Vihma, Hanna https://orcid.org/0000-0002-6128-636X
Li, Kelin
Welton-Arndt, Anna https://orcid.org/0009-0007-5629-8589
Smith, Audrey L. https://orcid.org/0009-0002-5982-463X
Bettadapur, Kiran R. https://orcid.org/0000-0003-3668-569X
Gilmore, Rachel B. https://orcid.org/0000-0001-7435-263X
Gao, Eric
Cotney, Justin L. https://orcid.org/0000-0001-8230-2157
Huang, Hsueh-Cheng
Collins, Jon L. https://orcid.org/0009-0007-8086-1802
Chamberlain, Stormy J.
Lee, Hyeong-Min https://orcid.org/0000-0002-9381-3611
Aubé, Jeffrey
Philpot, Benjamin D. https://orcid.org/0000-0003-2746-9143
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01NS131615, RO1NS129914, NS045892)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD094953, P50 HD103573)
Simons Foundation (#702556)
Angelman Syndrome Foundation
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development
Article History
Received: 4 January 2024
Accepted: 13 June 2024
First Online: 8 July 2024
Competing interests
: The authors performed the initial drug screen, shown in Fig. , as part of a sponsored research agreement with Pfizer that (1) provided the chemogenetic library, (2) partially supported H.-M.L.’s salary, and (3) provided research funds to perform the initial screen in the laboratory of B.D.P. No other parts of the project were supported by Pfizer. Pfizer reviewed and approved the manuscript submission, but did not contribute to the conceptualization, design, data collection, data analysis, or preparation of the manuscript. The authors do not have any other competing interests.